A large number of common drugs will reduce prices, some drugs reduce by more than 80%!

, the pharmaceutical network industry dynamics , Henan Province Public Resources Trading Center issued a notice that recently received some enterprises dynamic adjustment of the application of the linked drug hanging net limit price , Mosisha star tablets and other 65 downward lying net limit drugs to be announced , involving East Sunshine Pharmaceuticals , Zhengda Tianqing Pharmaceuticals , Stone Pharmaceutical Group Enbipu Pharmaceuticals , AstraZeneca and many other well-known pharmaceutical companies .
it is worth noting that among the 65 drugs, the original price limit of the Mosissa Sin tablet snuffed out 45 yuan, the adjusted price limit of 6.66 yuan, a decrease of more than 80%, followed by Wuhan Daan Pharmaceutical's fluorobilium injection shofer decreased by nearly 40%.
, there is also Zhuhai Federal Pharmaceutical's Meijin Angon oral solution and Zhengda Tianqing Pharmaceutical's pyrethic acid injections have both decreased by more than 20%.
in fact, since the implementation of the "4 plus 7" band procurement, there have been many pharmaceutical companies in a number of provinces and cities began to take the initiative to reduce prices.
this year in addition to Henan Province, Anhui, Shaanxi, Heilongjiang Province pharmaceutical procurement center has issued a drug price adjustment notice, a number of pharmaceutical companies actively apply for price reduction, involving a large number of common drugs.
for example, on March 31, Zhejiang Pharmaceutical Central Purchasing Center issued a "Notice on lowering the price of some online trading products linked (procurement)".
this price adjustment by Jiangsu Hengrui Pharmaceuticals and other enterprises to take the initiative, including Entikave dispersal tablets, including 14 drugs price reduction information was published.
price adjustments will be implemented from April 3, 2020. On the same day of
, Shaanxi Province Pharmaceutical Sourcing Center also issued a "notice on adjusting the price of some products hanging online."
according to the notice, its price adjustment by Qilu Pharmaceutical, Jiangsu Haussen and other enterprises to apply for the initiative, including Cargreco net tablets, including 6 drugs price reduction information was published.
according to statistics, in the previous period of large decline in the drug is Sichuan Collum Pharmaceuticals production of sodium bicarbonate ringer injection (1000ml), the price from 498.1 yuan to 108.8 yuan, a drop of nearly 80%.
in fact, the industry has analysis that under the role of health insurance leverage, combined with clinical control fees and other assessment requirements, these products are not selected to reduce prices is an inevitable trend.
because, in accordance with the requirements of the State Health Insurance Administration issued in early March, in principle, the purchase price will also be the price paid by some patients, more than the cost of some patients pay;
if companies want to keep prices high, they will quickly lose the market.
in general, companies actively apply for price reduction, are intended to seize more market share.
some are affected by their own strategy adjustment, but more by the "4 plus 7" band purchase expansion.
the future, with the country's provinces "4 plus 7" band procurement work continues to deepen, drug price reduction will become a trend, more selected drugs and varieties of products will face a collective drug price dive.
.